Nanovision Technology, a China-based radiology-imaging system developer backed by Legend Capital – the venture capital firm launched by conglomerate Legend Holdings – has secured RMB160m ($23m) in funding, VCbeat has reported.
Venture capital firm Sherpa Venture Capital led the series B round, which took Nanovision’s total funding to approximately $43m, China Money Network reported.
Founded in 2014, Nanovision provides X-ray imaging technology that can produce precision images of radiology cancer treatment in a relatively short time. It will use the funding to commercialise its product.
The company’s earlier funding was supplied by Legend Capital, Sherpa Venture Capital (then known as Sherpa Capital) and hedge fund manager Hillhouse Capital, according to China Money Network.
